Danyelle Townsend to Cost-Benefit Analysis
This is a "connection" page, showing publications Danyelle Townsend has written about Cost-Benefit Analysis.
Connection Strength
0.031
-
Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis. Biomed Pharmacother. 2017 Jun; 90:665-669.
Score: 0.031